KDM5C:在癌症生物学中的双边表观遗传调节器 - - 环境依赖的作用和治疗影响
Fei-Yang Tu1, Yan-Jun Liu2, Xiang Li2
1State Key Laboratory for Quality and Safety of Agro-products, School of Marine Sciences, Ningbo University, Ningbo 315211 Zhejiang, China.
Biochemical pharmacology
|September 13, 2025
概括
氨酸特异性去甲基酶5C (KDM5C) 是一种表观遗传调节剂,在癌症中具有双重作用. 它抑制癌中的瘤,但在其他癌症中驱动进展,提供取决于背景的治疗潜力.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
背景情况:
- 氨酸特异性脱甲基酶5C (KDM5C) 是一种调节H3K4甲基化的基因组脱甲基酶.
- KDM5C在癌症中表现出取决于情境的作用,作为瘤抑制剂或瘤驱动剂.
- 它的失调与各种癌症和神经发育障碍有关.
研究的目的:
- 综合KDM5C在疾病发病过程中的多方面的作用.
- 突出KDM5C的取决于环境的功能和治疗机会.
- 确定KDM5C向治疗的挑战和未来方向.
主要方法:
- 文献综述和现有临床前和临床数据的综合.
- 对KDM5C与关键调节器 (ARX,Smad3,HIF1α) 的相互作用进行分析.
- 检查染色体重塑和表观遗传调节机制.
主要成果:
- 通过保持基因组稳定性,KDM5C作为清细胞脏细胞癌 (ccRCC) 的瘤抑制剂.
- 在前列腺,乳腺和肝细胞癌中,KDM5C充当瘤驱动剂,促进EMT和化学抵抗.
- KDM5C的功能通过与调节蛋白和染色质重塑的相互作用来调节.
结论:
- KDM5C是一种关键的表观遗传调节剂,在不同类型的癌症中具有相反的作用.
- 了解KDM5C的上下文依赖功能对于开发向疗法至关重要.
- 未来的研究应该专注于精密疗法,整合单细胞奥米克和向抑制剂.
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
M-Cdk Drives Transition Into Mitosis
6.3K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K


